Drug discovery today

Triple-negative breast cancer brain metastasis: An update on druggable targets, current clinical trials, and future treatment options

Journal of Clinical Medicine

Current therapeutic strategies for metastatic triple-negative breast cancer: From pharmacists’ perspective

ASCO 2023, Journal of Clinical Oncology

The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction

Oncologist

Incidence and resolution of eribulin-induced peripheral neuropathy (IRENE) in locally advanced or metastatic breast cancer: Prospective cohort study

European Journal of Cancer

Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort

Breast Cancer Research and Treatment

Investigating potential immune mechanisms of trilaciclib administered prior to chemotherapy in patients with metastatic triple-negative breast cancer

Critical Reviews in Oncology/Hematology

Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey

Breast Cancer: Basic and Clinical Research

Implementation of risk-stratified breast cancer prevention with a polygenic risk score test in clinical practice

The ASCO Post

Current management of and future possibilities for triple negative breast cancer

Breast Cancer: Basic and Clinical Research

Real-world survival and treatment regimens across first- to third-line treatment for advanced triple-negative breast cancer